From 2003 at the forefront of supporting Sub-Saharan Africa’s response to poverty-related infectious diseases, EDCTP plays a key role also in the African response to Covid-19

Home / Healthcare and public health research / From 2003 at the forefront of supporting Sub-Saharan Africa’s response to poverty-related infectious diseases, EDCTP plays a key role also in the African response to Covid-19

From 2003 at the forefront of supporting Sub-Saharan Africa’s response to poverty-related infectious diseases, EDCTP plays a key role also in the African response to Covid-19

October 27, 2020 Dario Scaramuzzi 0 Comments 9 tags

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between countries in Europe and sub-Saharan Africa, supported by the European Union, which since 2003 has been accelerating the clinical development of new or improved medicines for the identification, treatment and prevention of poverty-related infectious diseases, is also at the forefront of supporting Sub-Saharan Africa’s response to COVID-19 https://bit.ly/2TDonGd idー19

Explore More

Liberia

With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),

AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out

From 2003 at the forefront of supporting Sub-Saharan Africa’s response to poverty-related infectious diseases, EDCTP plays a key role also in the African response to Covid-19

Leave a Reply Cancel reply

Explore More

Liberia

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

AfriNEXT